Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Kumps, Candy ^a   Van Roy, Nadine ^a   Heyrman, Lien ^b,c   Goossens, Dirk ^b,c   Del Favero, Jurgen ^b,c   Noguera, Rosa ^d   Vandesompele, Jo ^a   Speleman, Frank ^a   De Preter, Katleen ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 3P; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; COST; FALSE NEGATIVE RESULT; GENE LOCUS; HUMAN; INTERMETHOD COMPARISON; MULTIPLEX AMPLICON QUANTIFICATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; NEUROBLASTOMA; NUMERICAL CHROMOSOME ABERRATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; ECONOMICS; EVALUATION; GENETICS; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION;

DNA COPY NUMBER VARIATIONS; HUMANS; NEUROBLASTOMA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 77951995596     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-298     Document Type: Article

References (24)

1. Costa JL, Meijer G, Ylstra B, Caldas C. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Semin Radiat Oncol 2008, 18(2):98-104. 10.1016/j.semradonc.2007.10.005, 18314064.
2. Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today 2008, 13(17-18):760-770. 10.1016/j.drudis.2008.06.007, 18617013.
3. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30(12):e57. 10.1093/nar/gnf056, 117299, 12060695.
4. den Dunnen JT, White SJ. MLPA and MAPH: sensitive detection of deletions and duplications. Curr Protoc Hum Genet 2006, Chapter 7(Unit 7):14.
5. Multiplicon the multiplex experts. , http://www.multiplicon.com
6. Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, Kamali K, Corsmit E, De Leenheir E, Martin JJ, De Deyn PP, et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain 2006, 129(Pt 11):2984-2991. 10.1093/brain/awl212, 16931535.
7. Bogaerts V, Engelborghs S, Kumar-Singh S, Goossens D, Pickut B, Zee J, Sleegers K, Peeters K, Martin JJ, Del-Favero J, et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 2007, 130(Pt 9):2277-2291. 10.1093/brain/awm167, 17681982.
8. Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, Del-Favero J, Cruts M, van Duijn CM, Van Broeckhoven C. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 2006, 129(Pt 11):2977-2983. 10.1093/brain/awl203, 16921174.
9. Goossens D, Moens LN, Nelis E, Lenaerts AS, Glassee W, Kalbe A, Frey B, Kopal G, De Jonghe P, De Rijk P, et al. Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat 2009, 30(3):472-476. 10.1002/humu.20873, 19058222.
10. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003, 3(3):203-216. 10.1038/nrc1014, 12612655.
11. Van Roy N, De Preter K, Hoebeeck J, Van Maerken T, Pattyn F, Mestdagh P, Vermeulen J, Vandesompele J, Speleman F. The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy. Genome Med 2009, 1(7):74. 10.1186/gm74, 19638189.
12. Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V, Lastowska M, et al. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol 2005, 23(10):2280-2299. 10.1200/JCO.2005.06.104, 15800319.
13. Michels E, Vandesompele J, De Preter K, Hoebeeck J, Vermeulen J, Schramm A, Molenaar JJ, Menten B, Marques B, Stallings RL, Combaret V, Devalck C, De Paepe A, Versteeg R, Eggert A, Laureys G, Van Roy N, Speleman F. ArrayCGH-based classification of neuroblastoma into genomic subgroups. Genes Chromosomes Cancer 2007, 46(12):1098-108. 10.1002/gcc.20496, 17823929.
14. Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, et al. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. Oncogene 2008, 27(4):441-449. 10.1038/sj.onc.1210661, 17637744.
15. Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, et al. Overall genomic pattern is a predictor of outcome in neuroblastoma. J Clin Oncol 2009, 27(7):1026-1033. 10.1200/JCO.2008.16.0630, 19171713.
16. Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009, 100(9):1471-1482. 10.1038/sj.bjc.6605014, 2694415, 19401703.
17. MRC-Holland (MLPA). , http://www.mrc-holland.com
18. MRC Coffalyser MLPA-Dat. , http://old.mlpa.com/coffalyser
19. Villamón E, Piqueras M, Mackintosh C, Alonso J, de Alava E, Navarro S, Noguera R. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma. Virchows Arch 2008, 453(1):47-55. 10.1007/s00428-008-0633-6, 18574593.
20. Arraycghbase. , http://medgen.ugent.be/arrayCGHbase
21. Menten B, Pattyn F, De Preter K, Robbrecht P, Michels E, Buysse K, Mortier G, De Paepe A, van Vooren S, Vermeesch J, et al. arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics 2005, 6:124. 10.1186/1471-2105-6-124, 1173083, 15910681.
22. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5(4):557-572. 10.1093/biostatistics/kxh008, 15475419.
23. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999, 8(2):135-160. 10.1191/096228099673819272, 10501650.
24. van Houte BP, Binsl TW, Hettling H, Pirovano W, Heringa J. CGHnormaliter: an iterative strategy to enhance normalization of array CGH data with imbalanced aberrations. BMC Genomics 2009, 10(1):401. 10.1186/1471-2164-10-401, 2748095, 19709427.